Premium
This is an archive article published on February 3, 2023

To prevent cancer, more women should consider removing fallopian tubes, experts say

A top research group is urging even women without genetic risks to have their fallopian tubes removed under certain circumstances to prevent ovarian cancer.

Ovarian CancerMonica Monfre Scantlebury, who discovered she had the BRCA1 genetic mutation in 2017, in St. Paul, Minn., on Jan. 27, 2022. Scantlebury had multiple surgeries after discovering she carried a genetic mutation that raised the risk of ovarian and breast cancer; ÒI am named after my grandmother, and I believe the surgery prevented me from having the same obituary as her,Ó she said. (Jenn Ackerman/The New York Times)

Written by Roni Caryn Rabin

There is no reliable screening test for ovarian cancer, so doctors urge women at high genetic risk for the disease to have their ovaries and fallopian tubes removed once they are done having children, usually around the age of 40.

On Wednesday, a leading research and advocacy organization broadened that recommendation in ways that may surprise many women.

Story continues below this ad

Building on evidence that most of these cancers originate in the fallopian tubes, not the ovaries, the Ovarian Cancer Research Alliance is urging even women who do not have mutations — that is, most women — to have their fallopian tubes surgically removed if they are finished having children and are planning a gynecologic operation anyway.

In such a procedure, surgeons remove the tubes, which lead from the ovaries to the uterus, but leave the ovaries intact. The ovaries produce hormones that are beneficial even later in life, reducing the risk of heart disease, osteoporosis and sexual dysfunction. Sparing the organs has been linked to lower mortality overall.

Ovarian cancer is a relatively rare disease, and typically, we don’t message to the general population,” said Audra Moran, president and CEO of the OCRA. “We want everyone with ovaries to know their risk level and know the actions they can take to help prevent ovarian cancer.”

To that end, the group also has begun offering free at-home testing kits to qualifying women who want to find out if they carry genetic mutations such as BRCA1 and BRCA2, which confer an elevated risk for developing both ovarian and breast cancer.

Story continues below this ad

Younger carriers of the mutations might consider removing only the fallopian tubes as an interim step to protect against ovarian cancer and to avoid abrupt early menopause, Moran said, even though the gold-standard treatment for carriers is to remove the ovaries, too.

While women with BRCA1 and BRCA2 mutations have a very high risk for ovarian cancer, a majority of women with the disease do not carry the mutations.

Ovarian cancer ranks fifth in cancer deaths among women, according to the American Cancer Society, and accounts for more deaths than any other cancer of the female reproductive system. Every year, some 19,710 women in the United States have ovarian cancer diagnosed, and about 13,000 women die of it.

The disease is a particularly stealthy malignancy, and it is often diagnosed at a very advanced stage as a result.

Story continues below this ad

📣 For more lifestyle news, follow us on Instagram | Twitter | Facebook and don’t miss out on the latest updates!


📣 For more lifestyle news, click here to join our WhatsApp Channel and also follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement